Nanopharmaceutical Advanced Delivery Systems

Vivek Dave, Nikita Gupta, Srija Sur, Vivek Dave, Nikita Gupta, Srija Sur

• Publisher: Wiley-Scrivener
• Year: 2020
• Print ISBN: 9781119711667
• eBook ISBN: 9781119711681
• Edition: 1
• Topic: Computer Science
• Subtopic: Computer Engineering
• Index: Computer Science

The book provides a single volume covering detailed descriptions about various delivery systems, their principles and how these are put in use for the treatment of multiple diseases. It is divided into four sections where the first section deals with the introduction and importance of novel drug delivery system. The second section deals with the most advanced drug delivery systems like microbubbles, dendrimers, lipid-based nanoparticles, nanofibers, microemulsions etc., describing the major principles and techniques of the preparations of the drug delivery systems. The third section elaborates on the treatments of diverse diseases like cancer, topical diseases, tuberculosis etc. The fourth and final section provides a brief informative description about the regulatory aspects of novel drug delivery system that is followed in various countries.

Part 1
INTRODUCTION TO THE FUNDAMENTALS

1
Lipid-Based Nanocarriers as Drug Delivery System and Its Applications

Vikas Jain^*, Hitesh Kumar, Pallavi Chand, Sourabh Jain and Preethi S

Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, India

Abstract

Various nanotechnology platforms have received notable attention in the field of medical biology, including diagnostics and therapy. In addition, research and development of engineered multifunctional nanoparticles as drug carriers has stimulated exponential development of applications in medicine. Lipid nanocarriers have been a very promising tool for the delivery of various drugs/therapeutic agents associated with solubility-, bioavailability-, and stability-related issues. Lipid nanocarriers including liposomes, solid lipid-based systems, self-emulsifying drug delivery system, nanoemulsions, nanostructured lipid carriers, cubosomes and hexosomes, etc. are being very promising lipidic carriers to deliver several drugs, therapeutics nucleic acids, antibodies, proteins/peptides, or ligand targeted agents. Lipids-based nanocarriers have the benefit of having exciting physicochemical behaviors such as higher bioavailability, least toxicity, higher drug loading, greater drug solubility, improved targeting effect of drug, etc. compared to others nanocarriers. This chapter includes the challenges and hurdles in lipid nano-formulations and their application in drug delivery in various diseases. The chapter provides a brief description of advantage, types of lipid nanocarriers, their preparation method, characteristic properties, and characterization/evaluation methods including instrumentations and application in the nanopharmaceutical field.

Keywords: Crystalline mesophases, drug delivery system, liposome, lipid nanocarriers, nanostructured lipid carriers, nanoemulsions, self-emulsifying drug delivery system, solid lipid nanoparticles

List of Abbreviations

SLNs	Solid lipid nanoparticles (SLNs)
NLCs	Nanostructured lipid carriers
SEDDS	Self-emulsifying drug delivery system
LDC	Lipid drug conjugate hydrophilic
HLB	Lipophilic balance (HLB)
SMEDDS	Self-Micro Emulsifying Drug Delivery System
SNEDDS	Self-Nano Emulsifying Drug Delivery System
FT-IR	Fourier-transform infrared spectroscopy
NMR	Nuclear magnetic resonance
MS	Mass spectrometry
XRD	X-ray diffraction
TGA	Thermal gravimetrical analysis
DSC	Differential scanning calorimetry
DLS	Dynamic light scattering
PCS	Photon correlation spectroscopy
SEM	Scanning electro-microscopy
TEM	Transmission electron microscopy
PLM	Polarized light microscopy
AFM	Atomic Force Microscopy

1.1 Introduction

Evolution and application of the nanotechnology in pharmaceutical field have brought the development of microscopic drug delivery systems, which have marked the birth of “micro age” drug delivery systems [1]. The beginning of the nano period can be dated back to the late 1970s as a result of the introduction of several nano tools known as nanoscaled medicine systems. A wide variety of colloidal drug carriers including polymer nanosphere and nano-capsules, lipid nanoparticles, liposomes, and micelles are involved in nanoscaled drug delivery systems.

Presently, the development of drugs in the industry is more difficult and challenging because of an increasing number of poorly soluble drug(s) and the lack of targeted therapies. More than 90% of the recorded compounds have water insolubilities and/or are poorly soluble, often due to low bioavailability and a wide intra- and intersubject variation and lack of dosage efficacy [2, 3]. To address these issues, drug formulators need to look for new methods and novel formulation strategies and to ensure effective treatments for vulnerable patients.

Various nanotechnology platforms have received notable attention in the field of medical biology, including diagnostics and therapy. In addition, multifunction nanoparticles as drug carriers have stimulated rapid development of medical applications. Nanoparticles also have superiorities such as increasing drug stability and preventing adverse reactions by prolonged drug release behaviors [4, 5].

Formulating drug delivery system of active compounds with poor aqueous solubility using lipid-based systems is one of the promising strategies. Lipid provides a better alternative for the delivery of various drugs that suffer from solubility-, bioavailability-, and stability-related issues. In many studies, lipid formulations have been tried to increase bioavailability and dissolution of drugs, which are water insoluble [6]. The spontaneous emulsification in aqueous media is one of the major benefits by imparting such carriers to promote delivery of poorly soluble drugs.

Various literatures reported the characteristics and essential properties, design and development, utilization, and potential applications of various lipid-based nanocarriers in drug delivery [7, 8]. The current chapter discusses various lipid-based nanocarriers such as solid-lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), vesicular nanocarriers including liposomes, nanoemulsions, self-emulsifying drug delivery system (SEDDS), and crystalline mesophases in various application pharmaceutical fields. The information on the formulation components and processing aspects has also been discussed in detail.

1.2 An Overview on Nanocarriers

In the early 1990s, solid polymers in nanoparticles consisting of non-biodegradable and biodegradable polymers having size from 10 to 1000 nm with site-specific delivery feature and regulated drug release were developed. However, the major problem encountered was the higher cytotoxicity associated with these polymers [9-11]. Therefore, lipid-derived carriers emerged as a keystone for novel formulations because of its low cytotoxicity.

In the past two decades, the development of lipid-based drug carriers has received greater attention. Lipid nanoparticles offer several potential uses in the fields of drugs delivery, clinical medicine, research, and other varied sciences. Due to their unusual dimensional dependency, lipid nanoparticles provide the opportunity to develop new therapeutics. A new prototype in drug delivery for secondary and tertiary targeting can be made possible by incorporating the drug into these nanocarriers [12].

The first liposomes were introduced by Dior in 1986 to the cosmetic market. After several years, liposomes in the form of pharmaceutical products appeared in the market. As a novel carrier, liposomes were not only technically advanced but also have gained wide public interest. There are several other concepts of formulation; for example, microemulsions, nanoemulsions, and solid particles (such as microsponge) were also explored in the last two decades. Nevertheless, these nanocarriers have not been found in wide applications and have not gained any attention like liposomes.

SLNs have certain benefits in...

Table of contents

• Cover
• Title page
• Copyright
• Preface
• Part 1: INTRODUCTION TO THE FUNDAMENTALS
• Part 2: NOVEL AND MODERNIZED NANOSCALE DELIVERY SYSTEMS: REVOLUTIONARY PROGRESS IN THE FIELD OF PHARMACY
• Part 3: UNDERSTANDING TARGETED DELIVERY SYSTEMS
• Part 4: OVERVIEW OF REGULATORY AFFAIRS
• Index
• End User License Agreement